Color cases should be printed in color to optimize their effectiveness. Gilead Sciences, the U.S. leader in HIV/AIDS medicines, with global sales of $5.4 billion in 2009, had undertaken quite a lot of progressive actions to make its antiviral products accessible to over 100 low- and middle-income nations.
Having attained roughly 680,000 patients by the midst of 2009, the firm's senior managers contemplated how to reach 2 million patients by 2012.
PUBLICATION DATE: October 08, 2009 PRODUCT #: 510029-HCC-ENG
This is just an excerpt. This case is about SALES & MARKETING
Related Case Solutions & Analyses:
Changing the Channel: Better Way To Do Trade Promotions
Financial Management and Planning with the Product Life Cycle Concept
Fingerhuts Price Strategy
Memo (Dell)
Volkswagen India: Das Auto Digitally
Lakshmi Projects: Sales Structure Dilemma
Drowling Mountain
Steve Jackson Faces Resistance to Change
Fonterra
Can You Measure the ROI of Your Social Media Marketing?
